I am a
Home I AM A Search Login

Papers of the Week

Papers: 8 Jan 2022 - 14 Jan 2022

Human Studies

2021 Dec

Neurol Clin Pract



Erenumab Discontinuation After 12-Month Treatment: A Multicentric, Observational Real-Life Study.


di Cola F S, Caratozzolo S, Venturelli E, Balducci U, Sidoti V, Pari E, Costanzi C, di Summa A, Sixt G J, D'Adda E, Liberini P, Rao R, Padovani A
Neurol Clin Pract. 2021 Dec; 11(6):e834-e839.
PMID: 34992966.


To assess migraine outcome after 12-month treatment with erenumab and compare patients who underwent 3-month erenumab discontinuation following the first treatment cycle with those who continued monthly administrations.